Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.
Resources & Support
References
First Author
Abu-Taha, M
Title
Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan.
Citation
Journal of immunology (Baltimore, Md. : 1950); 2009 Jul 15; 183(2) pg1393-402
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
ELISA
First Author
Mateo, T
Title
A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles.
Citation
Blood; 2007 Sep 15; 110(6) pg1895-902
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
ELISA
Human
Immunostaining
Rat
ELISA
Rat
ELISA
Rat
ELISA
Rat
Immunostaining
Rat
Immunostaining
Rat
ELISA
Rat
ELISA
Rat
Immunostaining
Rat
Immunostaining
Rat
Immunostaining
Rat
Immunostaining
Rat
Immunostaining
First Author
Kuwata, H
Title
Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway.
Citation
The Journal of Biological Chemistry; 2005 Jul 8; 280(27) pg25830-9
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Nabah, Y N
Title
Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines.
Citation
Circulation; 2004 Dec 7; 110(23) pg3581-6
PubMed ID
showing 4 of 4
Quick Order: Upload CSV Instructions
Navigate to the CSV file of PeproTech products on your computer. Click on the file name to highlight it. Then, click "Open" in the dialog box. Items will load on the Quick Order form.
Coming Soon
This feature is coming soon.